Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients

被引:0
作者
Franco Maggiolo
Roberto Gulminetti
Layla Pagnucco
Margherita Digaetano
Adriana Cervo
Daniela Valenti
Annapaola Callegaro
Cristina Mussini
机构
[1] ASST Papa Giovanni XXIII,Division of Infectious Diseases
[2] Fondazione IRCCS Policlinico San Matteo,Division of Infectious Diseases
[3] University of Modena,Division of Infectious Diseases
[4] ASST Papa Giovanni XXIII,Microbiology and Virology Laboratory
[5] Fondazione FROM,undefined
来源
BMC Infectious Diseases | / 22卷
关键词
Dual ART; Dolutegravir; Lamivudine; Switch; Simplification; Long-term follow-up; Cohort;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
[41]   Long-term efficacy and safety of fixed-dose dolutegravir-lamivudine in people with HIV: A retrospective study from India. [J].
Kulkarni, Vinay ;
Parchure, Ritu ;
Gundu, Shridevi ;
Darak, Trupti ;
Kurkute, Kailas ;
Kulkarni, Ketan .
INTERNATIONAL JOURNAL OF STD & AIDS, 2025,
[42]   Dolutegravir-based anti-retroviral therapy is effective and safe in HIV-infected paediatric patients [J].
Bruzzese, Eugenia ;
Lo Vecchio, Andrea ;
Smarrazzo, Andrea ;
Tambaro, Orsola ;
Palmiero, Giulia ;
Bonadies, Giovanni ;
Guarino, Alfredo .
ITALIAN JOURNAL OF PEDIATRICS, 2018, 44
[43]   Long-term therapy for chronic hepatitis B in HIV co-infected patients [J].
Pais, R. ;
Benhamou, Y. .
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2010, 34 :S136-S141
[44]   Effects of long-term lamivudine therapy in renal-transplant patients [J].
Kamar, N ;
Sandres-Saune, K ;
Ribes, D ;
Duffaut, M ;
Selves, J ;
Durand, D ;
Izopet, J ;
Rostaing, L .
JOURNAL OF CLINICAL VIROLOGY, 2004, 31 (04) :298-303
[45]   Long-term outcomes of HIV-infected children in Thailand: the Thailand Pediatric HIV Observational Database [J].
Phongsamart, Wanatpreeya ;
Hansudewechakul, Rawiwan ;
Bunupuradah, Torsak ;
Klinbuayaem, Virat ;
Teeraananchai, Sirinya ;
Prasithsirikul, Wisit ;
Kerr, Stephen J. ;
Akarathum, Noppadon ;
Denjunta, Sukanda ;
Ananworanich, Jintanat ;
Chokephaibulkit, Kulkanya .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 22 :19-24
[46]   No increased risk of hepatotoxicity in long-term use of nonnucleoside reverse transcriptase inhibitors in HIV-infected patients [J].
Van Welzen, B. J. ;
Mudrikova, T. ;
Arends, J. E. ;
Hoepelman, A. I. M. .
HIV MEDICINE, 2012, 13 (07) :448-452
[47]   Lamivudine Monotherapy Experience of Medium-term Outcomes in HIV-infected Children Unable to Adhere to Triple Therapy [J].
Linder, Verena ;
Goldswain, Cheree ;
Adler, Hugh ;
Carty, Craig ;
Harper, Kim ;
Jackson, Valerie ;
Lambert, John S. ;
Boon, Gerald .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (07) :E199-E205
[48]   Long-term clinical and surrogate marker effects of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients [J].
Herzmann, C. ;
Cuthbertson, Z. ;
Fosdick, L. ;
Fisher, M. ;
Nelson, M. ;
Perry, N. ;
Law, M. ;
Wand, H. ;
Janossy, G. ;
Johnson, M. A. ;
Youle, M. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (03) :583-586
[49]   Impact of Switching from Lopinavir/Ritonavir to Atazanavir/Ritonavir on Body Fat Redistribution in Virologically Suppressed HIV-Infected Adults [J].
Ferrer, Elena ;
del Rio, Luis ;
Martinez, Esteban ;
Curto, Jordi ;
Domingo, Pere ;
Ribera, Esteban ;
Negredo, Eugenia ;
Rosales, Joaquim ;
Saumoy, Maria ;
Ordonez, Jordi ;
Gatell, Josep M. ;
Podzamczer, Daniel .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (10) :1061-1065
[50]   Rilpivirine plus cobicistat-boosted darunavir as alternative to standard three-drug therapy in HIV-infected, virologically suppressed subjects: Final results of the PROBE 2 trial [J].
Maggiolo, Franco ;
Gianotti, Nicola ;
Comi, Laura ;
Di Filippo, Elisa ;
Fumagalli, Laura ;
Nozza, Silvia ;
Galli, Laura ;
Valenti, Daniela ;
Rizzi, Marco ;
Castagna, Antonella .
ANTIVIRAL THERAPY, 2021, 26 (3-5) :51-57